# Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS

> **NCT04392089** · — · UNKNOWN · sponsor: **Hvidovre University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- COVID-19
- Respiratory Failure

## Interventions

- **DEVICE:** Masimo, LidCO

## Key facts

- **NCT ID:** NCT04392089
- **Lead sponsor:** Hvidovre University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-01
- **Primary completion:** 2021-05-01
- **Final completion:** 2021-05-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04392089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04392089, "Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04392089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*